scholarly journals Establishment and Characterization of a Human Small Cell Osteosarcoma Cancer Stem Cell Line: A New PossibleIn VitroModel for Discovering Small Cell Osteosarcoma Biology

2016 ◽  
Vol 2016 ◽  
pp. 1-18 ◽  
Author(s):  
Gaia Palmini ◽  
Roberto Zonefrati ◽  
Cecilia Romagnoli ◽  
Alessandra Aldinucci ◽  
Carmelo Mavilia ◽  
...  

Osteosarcoma (OSA) is the most common primary malignant bone tumor, usually arising in the long bones of children and young adults. There are different subtypes of OSA, among which we find the conventional OS (also called medullary or central osteosarcoma) which has a high grade of malignancy and an incidence of 80%. There are different subtypes of high grade OS like chondroblastic, fibroblastic, osteoblastic, telangiectatic, and the small cell osteosarcoma (SCO). In this study, for the first time, we have isolated, established, and characterized a cell line of cancer stem cells (CSCs) from a human SCO. First of all, we have established a primary finite cell line of SCO, from which we have isolated the CSCs by the sphere formation assay. We have proved theirin vitromesenchymal and embryonic stem phenotype. Additionally, we have showed their neoplastic phenotype, since the original tumor bulk is a high grade osteosarcoma. This research demonstrates the existence of CSCs also in human primary SCO and highlights the establishment of this particular stabilized cancer stem cell line. This will represent a first step into the study of the biology of these cells to discover new molecular targets molecules for new incisive therapeutic strategies against this highly aggressive OSA.

2004 ◽  
Vol 72 (5) ◽  
pp. 224-229 ◽  
Author(s):  
Hossein Baharvand ◽  
Saeid Kazemi Ashtiani ◽  
Mojtaba Rezazadeh Valojerdi ◽  
Abdolhossein Shahverdi ◽  
Adeleh Taee ◽  
...  

2006 ◽  
Vol 74 (2-3) ◽  
pp. 81-90 ◽  
Author(s):  
Arundhati Mandal ◽  
Shabari Tipnis ◽  
Rajarshi Pal ◽  
Geeta Ravindran ◽  
Bipasha Bose ◽  
...  

2021 ◽  
Vol 52 ◽  
pp. 102234
Author(s):  
Cong Zhang ◽  
Yanxing Wei ◽  
Yanqi Zhang ◽  
Jingyuan Zhang ◽  
Qi Xing ◽  
...  

Cells ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 1303
Author(s):  
Rizwan Ali ◽  
Hajar Al Zahrani ◽  
Tlili Barhoumi ◽  
Alshaimaa Alhallaj ◽  
Abdullah Mashhour ◽  
...  

In vitro studies of a disease are key to any in vivo investigation in understanding the disease and developing new therapy regimens. Immortalized cancer cell lines are the best and easiest model for studying cancer in vitro. Here, we report the establishment of a naturally immortalized highly tumorigenic and triple-negative breast cancer cell line, KAIMRC2. This cell line is derived from a Saudi Arabian female breast cancer patient with invasive ductal carcinoma. Immunocytochemistry showed a significant ratio of the KAIMRC2 cells’ expressing key breast epithelial and cancer stem cells (CSCs) markers, including CD47, CD133, CD49f, CD44, and ALDH-1A1. Gene and protein expression analysis showed overexpression of ABC transporter and AKT-PI3Kinase as well as JAK/STAT signaling pathways. In contrast, the absence of the tumor suppressor genes p53 and p73 may explain their high proliferative index. The mice model also confirmed the tumorigenic potential of the KAIMRC2 cell line, and drug tolerance studies revealed few very potent candidates. Our results confirmed an aggressive phenotype with metastatic potential and cancer stem cell-like characteristics of the KAIMR2 cell line. Furthermore, we have also presented potent small molecule inhibitors, especially Ryuvidine, that can be further developed, alone or in synergy with other potent inhibitors, to target multiple cancer-related pathways.


Sign in / Sign up

Export Citation Format

Share Document